LOX-1 and ROS, inseparable factors in the process of endothelial damage

References

• Suzuki T, Kohno H, Hasegawa A, Toshima S, Amaki T, Kurabayashi M, et al. Diagnostic implications of circulating oxidized low density lipoprotein levels as a biochemical risk marker of coronary artery disease. Clin Biochem 2002;35: 347–353.
   Google Scholar
• Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, Aiba Y, et al. An endothelial receptor for oxidized low-density lipoprotein. Nature 1997;386:73–77.
   PubMed Web of Science ®Google Scholar
• Twigg MW, Freestone K, Homer-Vanniasinkam S, Ponnambalam S. The LOX-1 scavenger receptor and its implications in the treatment of vascular disease. Cardiol Res Pract 2012;2012:632408.
   PubMedGoogle Scholar
• Goyal T, Mitra S, Khaidakov M, Wang X, Singla S, Ding Z, et al. Current concepts of the role of oxidized LDL receptors in atherosclerosis. Curr Atheroscler Rep 2012;14:150–159.
   Web of Science ®Google Scholar
• Murase T, Kume N, Korenaga R, Ando J, Sawamura T, Masaki T, Kita T. Fluid shear stress transcriptionally induces lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ Res 1998;83:328–333.
   PubMedGoogle Scholar
• Lubrano V and Balzan S. LOX-1, a new marker of risk and prognosis in coronary artery disease?. Mol Cell Biochem 2013;383:223–230.
   Google Scholar
• Jono T, Miyazaki A, Nagai R, Sawamura T, Kitamura T, Horiuchi S. Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) serves as an endothelial receptor for advanced glycation end products (AGE). FEBS Lett 2002;511:170–174.
   PubMed Web of Science ®Google Scholar
• Mehta JL, Chen J, Hermonat PL, Romeo F, Novelli G. Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders. Cardiovasc Res 2006;69:36–45.
   PubMed Web of Science ®Google Scholar
• Kataoka H, Kume N, Miyamoto S, Minami M, Moriwaki H, Murase T, et al. Expression of lectin-like oxidized low density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation 1999;99:3110–3117.
   PubMed Web of Science ®Google Scholar
• Kita T, Kume N, Minami M, Hayashida K, Murayama T, Sano H, et al. Role of oxidized LDL in atherosclerosis. Ann N Y Acad Sci. 2001;947:199–205.
   PubMed Web of Science ®Google Scholar
• Cominacini L, Fratta Pasini A, Garbin U, Pastorino A, Rigoni A, Nava C, et al. The platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells. J Am Coll Cardiol 2003;41: 499–507.
   Google Scholar
• Xu S, Ogura S, Chen J, Little PJ, Moss J and Liu P. LOX-1 in atherosclerosis: biological functions and pharmacological modifiers. Cell Mol Life Sci 2013;70:2859–2872.
   PubMed Web of Science ®Google Scholar
• Moriwaki H, Kume N, Sawamura T, Aoyama T, Hoshikawa H, Ochi H, et al. Ligand specificity of LOX-1, a novel endothelial receptor for oxidized low density lipoprotein. Arterioscler Thromb Vasc Biol 1998;18:1541–1547.
   PubMed Web of Science ®Google Scholar
• Pirillo A, Norata GD, Catapano AL. LOX-1, OxLDL, and atherosclerosis. Mediators Inflamm 2013;2013:1–12. doi:10.1155/2013/152786.
   Web of Science ®Google Scholar
• Chen J, Liu Y, Liu H, Hermonat PL, Mehta JL. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) transcriptional regulation by Oct-1 in human endothelial cells: implications for atherosclerosis. Biochem J 2006;393: 255–265.
   Google Scholar
• Chen J, Liu Y, Liu H, Hermonat PL, Mehta JL. Molecular dissection of angiotensin II-activated human LOX-1 promoter. Arterioscler Thromb Vasc Biol 2006;26:1163–1168.
   Google Scholar
• Coles AH, Gannon H, Cerny A, Kurt-Jones E, Jones SN. Inhibitor of growth-4 promotes IkappaB promoter activation to suppress NF-kappaB signaling and innate immunity. Proc Natl Acad Sci U S A. 2010;107:11423–11428.
   Google Scholar
• Kashiwase K, Higuchi Y, Hirotani S, Yamaguchi O, Hikoso S, Takeda T, et al. CaMKII activates ASK1 and NF-kappaB to induce cardiomyocyte hypertrophy. Biochem Biophys Res Commun 2005;327:136–142.
   Google Scholar
• Cominacini L, Pasini AF, Garbin U, Davoli A, Tosetti ML, Campagnola M, et al. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J Biol Chem 2000;275:12633–12638.
   PubMed Web of Science ®Google Scholar
• Groeger G, Quiney C, Cotter TG. Hydrogen peroxide as a cell-survival signaling molecule. Antioxid Redox Signal 2009;11:2655–2671.
   PubMed Web of Science ®Google Scholar
• Dandapat A, Hu C, Sun L, Mehta JL. Small concentrations of ox-LDL induce capillary tube formation from endothelial cells via LOX-1-dependent redox-sensitive pathway. Arterioscler Thromb Vasc Biol 2007;27:2435–2442.
   PubMed Web of Science ®Google Scholar
• Kamata H, Manabe T, Oka S, Kamata K, Hirata H. Hydrogen peroxide activate IkappaB kinases through phosphorylation of serine residues in the activation loops. FEBS Lett 2002;519: 231–237.
   PubMed Web of Science ®Google Scholar
• Anilkumar N, Weber R, Zhang M, Brewer A, Shah AM. NOX4 and NOX2 NADPH oxidases mediate distinct cellular redox signaling response to agonist stimulation. Arterioscler Thromb Vasc Biol 2007;27: 2435–2442.
   Google Scholar
• Cominacini L, Rigoni A, Pasini AF, Garbin U, Davoli A, Campagnola M, Pastorino AM, et al. The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide. J Biol Chem 2001;276: 13750–13755.
   PubMed Web of Science ®Google Scholar
• Mehta JL, Li DY. Identification and autoregulation of receptor for ox-LDL in cultured human coronary artery endothelial cells. Biochem Biophys Res Commun 1998;248:511–514.
   PubMed Web of Science ®Google Scholar
• Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, et al. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 1992;99:683–690.
   PubMed Web of Science ®Google Scholar
• Abarquez RF. Microvascular disease relevance in the hypertension syndrome. Clin Hemorheol Microcirc 2003;29: 295–300.
   Google Scholar
• He Z, King GL. Microvascular complications of diabetes. Endocrinol Metab Clin North Am 2004;33:215–238.
   PubMed Web of Science ®Google Scholar
• Stokes K, Cooper D, Tailor A, Granger DN. Hypercholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide. Free Radic Biol Med 2002;33:1026–1036.
   PubMed Web of Science ®Google Scholar
• Lubrano V, Del Turco S, Nicolini G, Di Cecco P, Basta G. Circulating levels of lectin-like oxidized low-density lipoprotein receptor-1 are associated with inflammatory markers. Lipids 2008;43:945–950.
   PubMed Web of Science ®Google Scholar
• Ignarro LJ. Biosynthesis and metabolism of endothelium-derived nitric oxide. Ann Rev Pharmacol. Toxicol 1990;30:535–560.
   PubMed Web of Science ®Google Scholar
• Huie RE, Padmaja S. The reaction of no with superoxide. Free Radic Res Commun 1993; 18:195–199.
   PubMed Web of Science ®Google Scholar
• Chen XP, Xun KL, Wu Q, Zhang TT, Shi JS, Du GH. Oxidized low density lipoprotein receptor-1 mediates oxidized low density lipoprotein induced apoptosis in human umbilical vein endothelial cells: role of reactive oxygen species. Vasc Pharmacol 2007;47:1–9.
   PubMed Web of Science ®Google Scholar
• Li JM, Shah AM. Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Integr Comp Physiol 2004;287: R1014–R1030.
   PubMed Web of Science ®Google Scholar
• Mehta JL, Chen J, Yu F, Li DY. Aspirin inhibits ox-LDL-mediated LOX-1 expression and metalloproteinase-1 in human coronary endothelial cells. Cardiovasc Res 2004;64: 243–249.
   PubMed Web of Science ®Google Scholar
• Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 2012;32:2045–2051.
   PubMed Web of Science ®Google Scholar
• Hansson GK, Robertson AK, Soderberg-Naucler C. Inflammation and atherosclerosis. Ann Rev Pathol 2006;1: 297–329.
   PubMed Web of Science ®Google Scholar
• Lu J, Mitra S, Wang X, Khaidakov M, Mehta JL. Oxidative stress and lectin-like ox-LDL-receptor LOX-1 in atherogenesis and tumorigenesis. Antiox Redox Signal 2011;15: 2301–2333.
   PubMed Web of Science ®Google Scholar
• Holvoet P, Harris TB, Tracy RP, Verhamme P, Newman AB, Rubin SM, et al. Association of high coronary heart disease risk status with circulating oxidized LDL in the well-functioning elderly: findings from the Health, Aging, and Body Composition study. Arterioscler Thromb Vasc Biol 2003;23:1444–1448.
   PubMed Web of Science ®Google Scholar
• Holvoet P, Kritchevsky SB, Tracy RP, Mertens A, Rubin SM, Butler J, et al. The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. Diabetes 2004;53:1068–1073.
   PubMed Web of Science ®Google Scholar
• Segev A, Strauss BH, Witztum JL, Lau HK, Tsimikas S. Relationship of a comprehensive panel of plasma oxidized low-density lipoprotein markers to angiographic restenosis in patients undergoing percutaneous coronary intervention for stable angina. Am Heart J 2005;150:1007–1014.
   Google Scholar
• Li R, Mittelstein D, Fang K, Beebe T, Quigley K, Berliner J, Hsiai TK. Angiopoeitin-2 modulates Survivin expression in OxLDL-induced endothelial cell apoptosis. Biochem Biophys Res Commun 2011;417:619–622.
   Google Scholar
• Mattaliano MD, Huard C, Cao W, Hill AA, Zhong W, Martinez RV, et al. LOX-1-dependent transcriptional regulation in response to oxidized LDL treatment of human aortic endothelial cells. Am J Physiol Cell Physiol 2011;96:C1329–C1337.
   Google Scholar
• Salvayre R, Auge N, Benoist H, Negre-Salvayre A. Oxidized low-density lipoprotein-induced apoptosis. Biochem Biophys Acta 2002;30:213–221.
   Google Scholar
• Kataoka H, Kume N, Miyamoto S, Minami M, Morimoto M, Hayashida K, et al. Oxidized LDL Modulates Bax/Bcl-2 Through the Lectinlike Ox-LDL Receptor-1 in Vascular Smooth Muscle Cells. Arterioscler Thromb Vasc Biol 2001;21:955–960.
   PubMed Web of Science ®Google Scholar
• Wu CY, Tang ZH, Jiang L, Li XF, Jiang ZS, Liu LS. PCSK9 siRNA inhibits HUVEC apoptosis induced by ox-LDL via Bcl/Bax–caspase9–caspase3 pathway. Mol Cell Biochem 2012;359:347–358.
   PubMed Web of Science ®Google Scholar
• Rueckschloss U, Villmow M, Klöckner U. NADPH oxidase-derived superoxide impairs calcium transients and contraction in aged murine ventricular myocytes. Exp Gerontol 2010;45:788–796.
   PubMed Web of Science ®Google Scholar
• Ou HC, Song TY, Yeh YC, Huang CY, Yang SF, Chiu TH, et al. EGCG protects against oxidized LDL-induced endothelial dysfunction by inhibiting LOX-1-mediated signaling. J Appl Physiol (1985). 2010;108:1745–1756.
   Google Scholar
• Khaidakov M, Mitra S, Wang X, Ding Z, Bora N, Lyzogubov V, et al. Large impact of low concentration oxidized LDL on angiogenic potential of human endothelial cells: a microarray study. PLoS One 2012;7:e47421.
   PubMed Web of Science ®Google Scholar
• Wu FT, Stefanini MO, Mac Gabhann F, Kontos CD, Annex BH, Popel AS. A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use. J Cell Mol Med. 2010;14:528–552.
   PubMedGoogle Scholar
• Moulton KS. Angiogenesis in atherosclerosis: gathering evidence beyond speculation. Curr Opin Lipidol. 2006;17: 548–555.
   PubMed Web of Science ®Google Scholar
• Li D, Mehta JL. Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors. Arterioscler Thromb Vasc Biol 2000;20:1116–1122.
   PubMed Web of Science ®Google Scholar
• Hsieh HJ, Cheng CC, Wu ST, Chiu JJ, Wung BS, Wang DL. Increase of reactive oxygen species (ROS) in endothelial cells by shear flow and involvement of ROS in shear-induced c-fos expression. J Cell Physiol 1998;175:156–162.
   PubMed Web of Science ®Google Scholar
• Bolli R, Zughaib M, Li XY, Tang XL, Sun JZ, Triana JF, McCay PB. Recurrent ischemia in the canine heart causes recurrent bursts of free radical production that have a cumulative effect on contractile function. A pathophysiological basis for chronic myocardial “Stunning”. J Clin Invest 1995;96: 1066–1084.
   PubMed Web of Science ®Google Scholar
• Li D, Liu L, Chen H, Sawamura T, Mehta JL. LOX-1, an oxidized LDL endothelial receptor, induces CD40/CD40L signaling in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol 2003;23:816–821.
   PubMed Web of Science ®Google Scholar
• Koga K, Kenessey A, Powell S, Sison CP, Miller EJ, Ojamaa K. Macrophage migration inhibitory factor provides cardioprotection during ischemia/reperfusion by reducing oxidative stress. Antioxid Redox Signal 2011;14:1191–1202.
   PubMed Web of Science ®Google Scholar
• Li D, Williams V, Liu L, Chen H, Sawamura T, Romeo F, Mehta JL. Expression of lectin-like oxidized low-density lipoprotein receptors during ischemia-reperfusion and its role in determination of apoptosis and left ventricular dysfunction. J Am Coll Cardiol 2003;41:1048–1055.
   Google Scholar
• Nagase M, Kaname S, Nagase T, Wang G, Ando K, Sawamura T, Fujita T. Expression of LOX-1, an oxidized low-density lipoprotein receptor, in experimental hypertensive glomerulo-sclerosis. J Am Soc Nephrol 2000;11:1826–1836.
   PubMed Web of Science ®Google Scholar
• Li D, Saldeen T, Romeo F, Mehta JL. Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappaB. Circulation 2000;102:1970–1976.
   PubMed Web of Science ®Google Scholar
• Morawietz H, Rueckschloss U, Niemann B, Duerrschmidt N, Galle J, Hakim K, et al. Angiotensin II induces LOX-1, the human endothelial receptor for oxidized low-density lipoprotein. Circulation 1999;100:899–902.
   PubMed Web of Science ®Google Scholar
• Hu C, Dandapat A, Sun L, Marwali MR, Inoue N, Sugawara F, et al. Modulation of angiotensin II-mediated hypertension and cardiac remodeling by lectin-like oxidized low-density lipoprotein receptor-1 deletion. Hypertension 2008;52:556–562.
   PubMedGoogle Scholar
• The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821–828.
   PubMed Web of Science ®Google Scholar
• Kobayashi N, Honda T, Yoshida K, Nakano S, Ohno T, Tsubokou Y, Matsuoka H. Critical role of bradykinin-eNOS and oxidative stress-LOX-1 pathway in cardiovascular remodeling under chronic angiotensin-converting enzyme inhibition. Atherosclerosis 2006;187:92–100.
   PubMed Web of Science ®Google Scholar
• Aoki M, Nata T, Morishita R, Matsushita H, Nakagami H, Yamamoto K, et al. Endothelial apoptosis induced by oxidative stress through activation of NFkB: antiapoptotic effect of antioxidant agents on endothelial cells. Hypertension. 2001;38:48–55.
   PubMed Web of Science ®Google Scholar
• Rossig L, Hoffmann J, Hugel B, Mallat Z, Haase A, Freyssinet JM, et al. Vitamin C inhibits endothelial cell apoptosis in congestive heart failure. Circulation. 2001;104:2182–2187.
   PubMed Web of Science ®Google Scholar
• Kris-Etherton PM, Keen CL. Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health. Curr Opin Lipidol. 2002;13:41–49.
   PubMed Web of Science ®Google Scholar
• Dugas AJ, Castaneda-Acosta J, Bonin GC, Price KL, Fischer NH, Winston GW. Evaluation of the total peroxyl radical-scavenging capacity of flavonoids: structure-activity relationships. J Nat Prod. 2000;63:327–331.
   PubMed Web of Science ®Google Scholar
• Ou HC, Chou FP, Sheen HM, Lin TM, Yang CH, Huey-Herng Sheu W. Resveratrol, a polyphenolic compound in red wine, protects against oxidized LDL-induced cytotoxicity in endothelial cells. Clin Chem Acta. 2006;364:196–204.
   PubMedGoogle Scholar
• Zafarullah M, Li WQ, Sylvester J, Ahmad M. Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci 2003;60:6–20.
   PubMed Web of Science ®Google Scholar
• Lubrano V, Baldi S, Napoli D, Longo V. Beneficial effect of Lisosan G on cultured human microvascular endothelial cells exposed to oxidised low density lipoprotein. Indian J Med Res 2012;136:82–88.
   PubMed Web of Science ®Google Scholar
• Takanabe-Mori R, Ono K, Sowa N, Wada H, Takaya T, Horie T, et al. Lectin-like oxidized low-density lipoprotein receptor-1 is required for the adipose tissue expression of proinflammatory cytokines in high-fat diet-induced obese mice. Biochem Biophys Res Commun. 2010;398:576–80.
   Google Scholar
• Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 2004;43:1731–1737.
   PubMed Web of Science ®Google Scholar
• Uchida K, Suehiro A, Nakanishi M, Sawamura T, Wakabayashi I. Associations of atherosclerotic risk factors with oxidized low-density lipoprotein evaluated by LOX-1 ligand activity in healthy men. Clin Chem Acta. 2011;412: 1643–1647.
   Google Scholar
• Brinkley TE, Kume N, Mitsuoka H, Phares DA, Hagberg JM. Elevated soluble lectin-like oxidized LDL receptor-1 (sLOX-1) levels in obese postmenopausal women. Obesity 2008;16: 1454–1456.
   Google Scholar